Loading
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
Previous close
$34.25
−$0.45 · -1.30%
After-hours
$34.00
−$0.25 · -0.73%
Sep 9, 6:36 PM ET
Regular session · ET · Market data may be delayed.
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
Day range
Current $34.25
52-week range
Current $34.25
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
90
Deep Value
Sentiment
49
Mixed
Risk
39
Moderate Risk
Momentum
34
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
Day range
Current $34.25
52-week range
Current $34.25
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (GBP) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.59B GBP | 9.43B GBP | 9.16B GBP | 8.55B GBP | 7.24B GBP |
| Cost of goods sold | 3.48B GBP | 3.3B GBP | 3.22B GBP | 3.05B GBP | 2.56B GBP |
| Gross profit | 6.11B GBP | 6.13B GBP | 5.95B GBP | 5.51B GBP | 4.68B GBP |
| Research and development | — | 364M GBP | 330M GBP | 309M GBP | 295M GBP |
| Selling, general, and administrative | 3.37B GBP | 3.32B GBP | 3.31B GBP | 3.2B GBP | 2.83B GBP |
| Operating expenses | 3.13B GBP | 3.27B GBP | 3.26B GBP | 3.2B GBP | 2.83B GBP |
| Interest income | 12M GBP | 6M GBP | 8M GBP | 4M GBP | 8M GBP |
| Interest expense | 298M GBP | 281M GBP | 300M GBP | 182M GBP | 150M GBP |
| Depreciation and amortization | 663M GBP | 706M GBP | 717M GBP | 785M GBP | 724M GBP |
| Operating income | 2.98B GBP | 2.86B GBP | 2.68B GBP | 2.32B GBP | 1.88B GBP |
| Net income | 2.07B GBP | 1.93B GBP | 1.78B GBP | 1.63B GBP | 1.47B GBP |
Company facts updated Sep 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis International Equity ETFAVDE28.42M0.15%19.18B USD0.23%$92.97-0.77%
Dimensional International High Profitability ETFDIHP19.22M0.30%6.57B USD0.27%$34.71-1.00%
Invesco International Dividend Achievers ETFPID15.55M1.74%901.2M USD0.53%$22.4399-1.28%
Dimensional - International Core Equity 2 ETFDFIC11.99M0.08%15.54B USD0.22%$38.94-0.84%
Fidelity Enhanced International ETFFENI11.06M0.10%11.47B USD0.28%$40.88-1.14%
iShares Dynamic Equity Active ETFBDYN10.59M0.34%3.12B USD0.40%$27.98-0.69%
ActivePassive International Equity ETFAPIE6.49M0.56%953.79M USD0.45%$39.20-1.05%
First Trust NASDAQ Technology Dividend Index FundTDIV5.22M0.12%4.44B USD0.50%$115.54-0.44%Avantis International Equity ETFAVDEDimensional International High Profitability ETFDIHPInvesco International Dividend Achievers ETFPIDDimensional - International Core Equity 2 ETFDFICFidelity Enhanced International ETFFENIiShares Dynamic Equity Active ETFBDYNActivePassive International Equity ETFAPIEFirst Trust NASDAQ Technology Dividend Index FundTDIVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
